Hemostasis Valve Market

ID: MRFR/HC/27624-HCR

128 Pages

Rahul Gotadki

September 2025

Hemostasis Valve Market Research Report By Product Type (Mechanical Hemostasis Valves, Active Hemostasis Valves, Biodegradable Hemostasis Valves), By Material (Polytetrafluoroethylene (PTFE), Polypropylene (PP), Polyethylene Terephthalate (PET)), By Application (Cardiovascular Surgery, Pulmonary Embolism, Gastrointestinal Surgery, Urological Surgery), By Patient Population (Adults, Pediatric, Geriatric) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2034

Hemostasis Valve Market Research Report-Forecast till 2034 Infographic

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Infographic

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Hemostasis Valve Market Summary

The Global Hemostasis Valve Market is projected to grow from 1.59 USD Billion in 2024 to 2.65 USD Billion by 2035, reflecting a robust CAGR of 4.76%.

Key Market Trends & Highlights

Hemostasis Valve Key Trends and Highlights

The market is valued at 1.59 USD Billion in 2024 and is expected to reach 2.65 USD Billion by 2035.
The compound annual growth rate (CAGR) for the period from 2025 to 2035 is estimated at 4.76%.
This growth trajectory indicates a rising demand for hemostasis valves in various medical applications.
Growing adoption of advanced surgical techniques due to increased patient safety is a major market driver.

Hemostasis Valve Market

CAGR

4.76%

Market Size & Forecast

2024 Market Size	1.59 (USD Billion)
2035 Market Size	2.65 (USD Billion)
CAGR (2025-2035)	4.76%

Major Players

Terumo Medical Corporation, Merit Medical Systems, Inc., BD, Integra LifeSciences, L. Gore Associates, Cardinal Health, Braun Melsungen, Cook Medical, Gore Medical, Medtronic, Meditech, Smiths Medical, Teleflex

Hemostasis Valve Market Trends

As of 2023 and beyond, the global hemostasis valve market is poised for significant growth due to several key drivers. The increasing prevalence of vascular diseases, including venous thromboembolism, is driving the demand for hemostasis valves to prevent life-threatening complications.

Advances in medical technology, such as the development of minimally invasive and endovascular procedures, have further expanded the applications of hemostasis valves. This has led to a shift towards less invasive and effective methods for vascular interventions.

Emerging applications in endovascular surgery and a growing focus on patient safety in operating rooms have created substantial opportunities for market expansion. The rise of artificial intelligence (AI) and machine learning (ML) algorithms is expected to enhance the precision and efficiency of hemostasis valve placement, further driving market growth.

Additionally, the increasing awareness of hemostasis valve benefits among healthcare professionals and patients is expected to contribute to the market's growth.

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

The ongoing advancements in hemostasis valve technology appear to enhance procedural efficiency and patient outcomes, reflecting a broader trend towards innovation in medical devices.

U.S. Food and Drug Administration (FDA)

Hemostasis Valve Market Drivers

Increasing Surgical Procedures

The rise in surgical procedures globally is a primary driver for the Global Hemostasis Valve Market Industry. As healthcare systems evolve and improve, the number of surgeries performed continues to increase, leading to a higher demand for effective hemostasis solutions. For instance, the World Health Organization indicates that surgical interventions are essential for addressing various health conditions, thus contributing to the projected market value of 1.59 USD Billion in 2024. This trend is expected to persist, as advancements in surgical techniques and technologies enhance patient outcomes, further propelling the need for hemostasis valves.

Market Segment Insights

Hemostasis Valve Market Product Type Insights

The global hemostasis valve market is segmented based on product type into mechanical hemostasis valves, active hemostasis valves, and biodegradable hemostasis valves. Mechanical hemostasis valves held the largest market share in 2023, accounting for over 60% of the global market. These valves are preferred due to their durability, reliability, and cost-effectiveness.

Active hemostasis valves are expected to witness the highest growth rate during the forecast period, owing to their ability to provide rapid hemostasis and reduce blood loss. The market growth is attributed to the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive surgical procedures, and growing demand for advanced wound care products.

Key Insights Mechanical hemostasis valves are expected to remain the dominant segment throughout the forecast period due to their wide acceptance and proven efficacy. Active hemostasis valves are gaining traction due to their ability to provide faster hemostasis and reduce blood loss, particularly in complex surgical procedures.

Biodegradable hemostasis valves are expected to witness significant growth in the coming years due to their advantages, such as biocompatibility, reduced risk of infection, and elimination of the need for a second surgery.

The rising demand for hemostasis valves in emerging markets, such as Asia-Pacific and Latin America, is expected to drive market growth in the coming years. Technological advancements, such as the development of smaller and more efficient valves, are expected to further drive market growth.

Hemostasis Valve Market Material Insights

The Material segment of the Global Hemostasis Valve Market is expected to witness significant growth over the forecast period. The increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive surgeries are major factors driving the market growth.

Polytetrafluoroethylene (PTFE) held the largest market share in 2023 and is expected to maintain its dominance throughout the forecast period. PTFE is a synthetic fluoropolymer with excellent biocompatibility, chemical resistance, and low friction coefficient, making it ideal for use in hemostasis valves.

Polypropylene (PP) and Polyethylene Terephthalate (PET) are other commonly used materials in the manufacturing of hemostasis valves.

These materials offer a combination of strength, flexibility, and biocompatibility, making them suitable for various applications. The Global Hemostasis Valve Market revenue is projected to reach USD 2.2 billion by 2032, exhibiting a CAGR of 4.77% during the forecast period.

Hemostasis Valve Market Application Insights

The Global Hemostasis Valve Market Segmentation by Application includes Cardiovascular Surgery, Pulmonary Embolism,

, and Urological Surgery. The Cardiovascular Surgery segment held the largest market share in 2023, accounting for over 45% of the global market.

This is due to the high prevalence of cardiovascular diseases and the increasing number of cardiac surgeries performed worldwide. The Pulmonary Embolism segment is expected to grow at the highest CAGR during the forecast period, owing to the rising incidence of pulmonary embolism and the increasing adoption of hemostasis valves for its treatment.

The Gastrointestinal Surgery and Urological Surgery segments are also expected to witness significant growth, driven by the increasing number of surgeries performed in these areas.

The Global Hemostasis Valve Market is expected to reach a valuation of USD 1.6 billion by 2025, exhibiting a CAGR of 5.2% during the forecast period.

Hemostasis Valve Market Patient Population Insights

The patient population segment of the Global Hemostasis Valve Market is categorized into adults, pediatric, and geriatric patients. Adults represented the largest segment, accounting for over 60% of the market share in 2023.

The high prevalence of cardiovascular diseases and surgical interventions among the adult population contributes to the significant demand for hemostasis valves. The pediatric segment is expected to witness a steady growth rate during the forecast period, owing to the rising incidence of congenital heart defects and the increasing adoption of minimally invasive surgical techniques.

This growth is attributed to the rising prevalence of cardiovascular diseases, the increasing adoption of minimally invasive surgical techniques, and the growing geriatric population.

Get more detailed insights about Hemostasis Valve Market Research Report-Forecast till 2034

Request Free Sample

Regional Insights

The regional segmentation of the Global Hemostasis Valve Market provides insights into the market's geographic distribution and performance. North America is expected to dominate the market, driven by the presence of key players and a high prevalence of cardiovascular diseases.

Europe is projected to follow closely, with a significant market share due to well-established healthcare systems and technological advancements. APAC is anticipated to witness substantial growth, owing to rising healthcare expenditure and increasing adoption of advanced medical devices.

South America and MEA are expected to contribute moderately to the market, with growing awareness and improving healthcare infrastructure fueling growth.

Key Companies in the Hemostasis Valve Market market include

Industry Developments

The increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive surgical procedures, and technological advancements in hemostasis valve devices are major factors driving market growth.

Key developments in the market include the launch of innovative products such as the Hemostatic Valve System by Terumo Medical Corporation and the FDA approval of the Mantis Vascular Closure Device by Cardinal Health.

Strategic collaborations and acquisitions are also shaping the competitive landscape, with companies like Abbott Laboratories and BD acquiring smaller players to expand their product portfolios.

Future Outlook

Hemostasis Valve Market Future Outlook

The Hemostasis Valve Market is projected to grow at a 4.76% CAGR from 2024 to 2035, driven by technological advancements, increasing surgical procedures, and rising demand for minimally invasive surgeries.

New opportunities lie in:

Develop innovative hemostasis valve designs to enhance patient outcomes and reduce complications.
Expand distribution networks in emerging markets to capture untapped customer segments.
Invest in R&D for next-generation materials to improve valve durability and performance.

By 2035, the Hemostasis Valve Market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological advancements.

Market Segmentation

Hemostasis Valve Market Material Outlook

Polytetrafluoroethylene (PTFE)
Polypropylene (PP)
Polyethylene Terephthalate (PET)

Hemostasis Valve Market Regional Outlook

North America
Europe
South America
Asia Pacific
Middle East and Africa

Hemostasis Valve Market Application Outlook

Cardiovascular Surgery
Pulmonary Embolism
Gastrointestinal Surgery
Urological Surgery

Hemostasis Valve Market Product Type Outlook

Mechanical Hemostasis Valves
Active Hemostasis Valves
Biodegradable Hemostasis Valves

Hemostasis Valve Market Patient Population Outlook

Adults
Pediatric
Geriatric

Report Scope

Report Attribute/Metric	Details
Market Size 2024	1.59 (USD Billion)
Market Size 2025	1.66 (USD Billion)
Market Size 2034	2.53 (USD Billion)
Compound Annual Growth Rate (CAGR)	4.77 % (2025 - 2034)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2034
Historical Data	2020 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	BD, Merit Medical Systems, Integra LifeSciences, W. L. Gore Associates, Cardinal Health, B. Braun Melsungen, Cook Medical, Gore Medical, Medtronic, Meditech, Smiths Medical, Terumo, Teleflex
Segments Covered	Product Type, Material, Application, Patient Population, Regional
Key Market Opportunities	Increasing demand for minimally invasive surgeries, technological advancements, rising prevalence of vascular diseases, expanding geriatric population, and growing healthcare expenditure
Key Market Dynamics	Increasing prevalence of cardiovascular diseases Growing geriatric population Technological advancements Rising demand for minimally invasive procedures Expanding applications in cardiovascular surgeries
Countries Covered	North America, Europe, APAC, South America, MEA

FAQs

What was the market size of the Global Hemostasis Valve Market in 2023?

The global hemostasis valve market was valued at approximately 1.45 billion USD in 2023.

What is the projected CAGR of the Global Hemostasis Valve Market?

The market is expected to grow at a CAGR of 4.77% from 2025 to 2034.

Which region is expected to hold the largest market share in the Global Hemostasis Valve Market?

North America is expected to hold the largest market share due to the presence of a large number of key players and a high prevalence of cardiovascular diseases.

What are the key applications of hemostasis valves?

Hemostasis valves are primarily used in cardiovascular surgeries, such as heart valve replacement and repair procedures.

Who are some of the key competitors in the Global Hemostasis Valve Market?

Some of the key competitors include Abbott, Medtronic, Boston Scientific, and Terumo.

What are the major factors driving the growth of the Global Hemostasis Valve Market?

The increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive surgeries are major factors driving the growth of the market.

What are some of the challenges faced by the Global Hemostasis Valve Market?

Challenges include stringent regulatory requirements and the high cost of hemostasis valves.

What is the expected market size of the Global Hemostasis Valve Market in 2034?

The market is expected to reach approximately 2.53 billion USD by 2034.

What are the key trends expected to shape the future of the Global Hemostasis Valve Market?

Key trends include the development of innovative hemostasis valves and the increasing adoption of robotic surgeries.

What is the impact of technological advancements on the Global Hemostasis Valve Market?

Technological advancements are leading to the development of more effective and less invasive hemostasis valves.

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027